FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PRODUCT-SPECIFIC GUIDANCE ON IRON SUCROSE; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, Aug. 8 -- Food and Drug Administration has issued a notice called: Product-Specific Guidance on Iron Sucrose; Draft Guidance for Industry; Availability.

The notice was published in the Federal Register on Aug. 8 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry entitled "Draft Guidance on Iron Sucrose." This revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for iron sucrose intravenous injectable.

Fo...